Dinuclear ruthenium(II) polypyridyl complexes: Mechanistic study with biomolecules, DNA/BSA interactions and cytotoxic activity

Polyhedron ◽  
2020 ◽  
Vol 178 ◽  
pp. 114334 ◽  
Author(s):  
Milica Medjedović ◽  
Ana Rilak Simović ◽  
Dušan Ćoćić ◽  
Milan Milutinović ◽  
Laura Senft ◽  
...  
Molecules ◽  
2021 ◽  
Vol 26 (5) ◽  
pp. 1453
Author(s):  
Haoran Wang ◽  
Jianhua Wei ◽  
Hong Jiang ◽  
Ye Zhang ◽  
Caina Jiang ◽  
...  

The use of cisplatin is severely limited by its toxic side-effects, which has spurred chemists to employ different strategies in the development of new metal-based anticancer agents. Here, three novel dehydroabietyl piperazine dithiocarbamate ruthenium (II) polypyridyl complexes (6a–6c) were synthesized as antitumor agents. Compounds 6a and 6c exhibited better in vitro antiproliferative activity against seven tumor cell lines than cisplatin, they displayed no evident resistance in the cisplatin-resistant cell line A549/DPP. Importantly, 6a effectively inhibited tumor growth in the T-24 xenograft mouse model in comparison with cisplatin. Gel electrophoresis assay indicated that DNA was the potential targets of 6a and 6c, and the upregulation of p-H2AX confirmed this result. Cell cycle arrest studies demonstrated that 6a and 6c arrested the cell cycle at G1 phase, accompanied by the upregulation of the expression levels of the antioncogene p27 and the down-regulation of the expression levels of cyclin E. In addition, 6a and 6c caused the apoptosis of tumor cells along with the upregulation of the expression of Bax, caspase-9, cytochrome c, intracellular Ca2+ release, reactive oxygen species (ROS) generation and the downregulation of Bcl-2. These mechanistic study results suggested that 6a and 6c exerted their antitumor activity by inducing DNA damage, and consequently causing G1 stage arrest and the induction of apoptosis.


2003 ◽  
Vol 68 (8) ◽  
pp. 1467-1487 ◽  
Author(s):  
Wesley R. Browne ◽  
Frances Weldon ◽  
Adrian Guckian ◽  
Johannes G. Vos

The syntheses and characterisation of a series of mononuclear and dinuclear ruthenium polypyridyl complexes based on the bridging ligands 1,3-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]benzene, 1,4-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]benzene, 2,5-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]thiophene, 2,5-bis-[5-pyrazinyl-1H-1,2,4-triazol-3-yl]thiophene are reported. Electrochemical studies indicate that in these systems, the ground state interaction is critically dependent on the nature of the bridging ligand and its protonation state, with strong and weak interactions being observed for thiophene- and phenylene-bridged complexes, respectively.


2019 ◽  
Vol 43 (22) ◽  
pp. 8566-8579 ◽  
Author(s):  
Miao He ◽  
Qiao-Yan Yi ◽  
Wen-Yao Zhang ◽  
Lan Bai ◽  
Fan Du ◽  
...  

Three new iridium(iii) polypyridyl complexes were synthesized. The cytotoxic activity in vitro and in vivo, apoptosis, cell cycle arrest, mitochondrial membrane potential, ROS and the expression of Bcl-2 family proteins were investigated.


2017 ◽  
Vol 458 ◽  
pp. 122-128 ◽  
Author(s):  
Chao Shen ◽  
Aaron D.W. Kennedy ◽  
William A. Donald ◽  
Allan M. Torres ◽  
William S. Price ◽  
...  

2014 ◽  
Vol 50 (17) ◽  
pp. 2123 ◽  
Author(s):  
Wenchao Xu ◽  
Jiarui Zuo ◽  
Lili Wang ◽  
Liangnian Ji ◽  
Hui Chao

2004 ◽  
pp. 3943 ◽  
Author(s):  
Adrian L. Guckian ◽  
Manfred Doering ◽  
Michael Ciesielski ◽  
Olaf Walter ◽  
Johan Hjelm ◽  
...  

2020 ◽  
Vol 59 (7) ◽  
pp. 4424-4434 ◽  
Author(s):  
Alexandra-Cristina Munteanu ◽  
Anna Notaro ◽  
Marta Jakubaszek ◽  
Joseph Cowell ◽  
Mickaël Tharaud ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document